Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018219877) MEDIUM CHAIN FATTY ACIDS FOR USE IN THE PREVENTION OR TREATMENT OF CARDIAC ENLARGEMENT AND/OR VALVULAR HEART DISEASE
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/219877 International Application No.: PCT/EP2018/063958
Publication Date: 06.12.2018 International Filing Date: 28.05.2018
IPC:
A61K 31/23 (2006.01) ,A61K 31/19 (2006.01) ,A61K 31/20 (2006.01) ,A61K 31/225 (2006.01) ,A61K 45/06 (2006.01) ,A61K 31/355 (2006.01) ,A61K 31/185 (2006.01) ,A61K 31/198 (2006.01) ,A61K 33/06 (2006.01) ,A61P 9/04 (2006.01) ,A61P 9/06 (2006.01) ,A61P 9/00 (2006.01) ,A61P 9/12 (2006.01)
[IPC code unknown for A61K 31/23][IPC code unknown for A61K 31/19][IPC code unknown for A61K 31/20][IPC code unknown for A61K 31/225][IPC code unknown for A61K 45/06][IPC code unknown for A61K 31/355][IPC code unknown for A61K 31/185][IPC code unknown for A61K 31/198][IPC code unknown for A61K 33/06][IPC code unknown for A61P 9/04][IPC code unknown for A61P 9/06][IPC code unknown for A61P 9][IPC code unknown for A61P 9/12]
Applicants:
NESTEC S.A. [CH/CH]; Avenue Nestlé 55 1800 Vevey, CH
Inventors:
LI, Qinghong; US
BEAUMONT, Maurice; CH
Agent:
NAUDE, Dawn; CH
Priority Data:
62/512,11829.05.2017US
Title (EN) MEDIUM CHAIN FATTY ACIDS FOR USE IN THE PREVENTION OR TREATMENT OF CARDIAC ENLARGEMENT AND/OR VALVULAR HEART DISEASE
(FR) ACIDES GRAS À CHAÎNE MOYENNE DESTINÉS À ÊTRE UTILISÉS DANS LA PRÉVENTION OU LE TRAITEMENT D'UNE HYPERTROPHIE CARDIAQUE ET/OU D'UNE VALVULOPATHIE
Abstract:
(EN) Medium chain fatty acids or a composition comprising medium chain fatty acids for use in the prevention or treatment of cardiac enlargement, valvular heart disease and/or a condition associated with either of the foregoing in a human.
(FR) L'invention concerne des acides gras à chaîne moyenne ou une composition comprenant des acides gras à chaîne moyenne destinés à être utilisés dans la prévention ou le traitement de l'hypertrophie cardiaque, de la valvulopathie et/ou d'un état associé à l'un ou l'autre des éléments précédents chez un être humain.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)